Home

A Novel Treatment For Huntington's Disease

WELCOME TO PANDEIA THERAPEUTICS

 

We are a UK-based asset-centric start-up biotech developing small molecule candidates against a novel tractable GPCR target that is highly expressed in the striatum. Our candidates will have the potential in treating patients with neurodegenerative and neuropsychiatic disorders of high unmet need.

 

 

info@pandeiatherapeutics.com

Cambridge, UK

Incorporated in England and Wales with registered number 11464856

Copyright @ All Rights Reserved